EVR News Alert Evercore Partners Inc (EVR) 52.54 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evercore Partners Inc (EVR) 52.54 $EVR

Why This Under the Radar Internet of Things Stock Soared 53% in 2014
Chris Neiger, The Motley Fool - Motley Fool - Tue Dec 16, 9:00AM CST
While many stocks experience a series of ups and down throughout the year, it's been quite a ride for Freescale Semiconductors . The stock's currently up more than 53% year-to-date, and the coming year brings some big prospects for the company. ...
EVR: 52.54 (-0.16), CHL: 59.15 (-0.02), FSL: 25.48 (unch)

Do Morgan Stanley's Low Deferrals Hint Financial Strength? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 9:20AM CST
Morgan Stanley (MS) showcased its strengthening financial ability by bringing the employees' incentive compensation policy closer to the entire industry's long-term policy for the same.
GS: 195.89 (+0.39), EVR: 52.54 (-0.16), PJC: 57.44 (+0.20), MS: 38.81 (-0.14)

Can Schwab's Revenue Growth Prospects Attract Investors? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 10:10AM CST
Diversified revenue streams remain a major strength for Schwab, which is further expected to grow on its efforts to improve the same.
RJF: 57.73 (-0.02), EVR: 52.54 (-0.16), GCAP: 8.80 (-0.04), SCHW: 30.67 (+0.01)

Goldman Shows Revenue Growth & Cost Control; Should You Hold? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 10:20AM CST
On Nov 19, 2014, we issued an updated research report on The Goldman Sachs Group, Inc. (GS).
GS: 195.89 (+0.39), EVR: 52.54 (-0.16), PJC: 57.44 (+0.20), FXCM: 16.88 (-0.12)

Thomas B. Leonardi Agrees to Join Evercore as Senior Advisor
Business Wire - Wed Nov 19, 8:10AM CST
Evercore (NYSE:EVR), a leading independent investment banking advisory firm, today announced that Connecticut Insurance Commissioner Thomas B. Leonardi has agreed to join the firm as a senior advisor with a focus on the insurance industry sector. Mr. Leonardi has nearly 40 years of experience as an investment banker, venture capitalist, attorney, and insurance company president, and is widely regarded as a leading expert on systemic risk, group supervision, and international regulatory issues.
EVR: 52.54 (-0.16)

These Key Trends Point To A Bright Future For Investment Banks
Lester Goh - at Seeking Alpha - Tue Nov 18, 4:21PM CST

GHL: 43.02 (-0.18), LAZ: 50.95 (-0.37), EVR: 52.54 (-0.16), MC: 35.26 (+0.09)

Stocks Going Ex-Dividend The Fourth Week Of November
Stockerblog - at Seeking Alpha - Tue Nov 18, 3:35AM CST
Here is our latest update on the stock trading technique called "Buying Dividends," also commonly referred to as "Dividend Capture." This is the process of buying stocks before the ex-dividend date and selling the stock shortly...
STB: 6.13 (-0.02), STAG: 24.79 (-0.16), D: 78.38 (+1.48), NEE: 107.98 (+1.66), EVR: 52.54 (-0.16), FNB: 13.22 (-0.10), K: 67.02 (-0.22), LXK: 42.04 (+0.24)

Evercore President and Chief Executive Officer, Ralph L. Schlosstein, to Present at the Goldman Sachs US Emerging/SMID Cap Growth Conference on November 20, 2014
Business Wire - Thu Nov 13, 3:45PM CST
Evercore (NYSE:EVR) today announced that its President and Chief Executive Officer, Ralph L. Schlosstein, is scheduled to present at the Goldman Sachs US Emerging/SMID Cap Growth Conference on Thursday, November 20, 2014 at 8:50 a.m. Eastern Time.
EVR: 52.54 (-0.16)

The Best Small-Cap Dividend Growers: Capital Market Stocks
Stan Stafford - at Seeking Alpha - Thu Nov 13, 2:30PM CST

MKTX: 72.30 (+0.01), IBKR: 29.57 (+0.03), EVR: 52.54 (-0.16)

Evercore Chief Financial Officer, Robert B. Walsh, to Present at the KBW Securities Brokerage & Market Structure Conference on November 19, 2014
Business Wire - Wed Nov 12, 3:45PM CST
Evercore (NYSE:EVR) today announced that its Chief Financial Officer, Robert B. Walsh, is scheduled to present at the KBW Securities Brokerage & Market Structure Conference on Wednesday, November 19, 2014 at 3:15 p.m. Eastern Time.
EVR: 52.54 (-0.16)

Evercore Wealth Management Names Stephanie Hackett Managing Director, Portfolio Manager
Business Wire - Wed Nov 12, 7:00AM CST
Evercore Wealth Management LLC today announced the appointment of Stephanie Hackett as a Managing Director and Portfolio Manager.
EVR: 52.54 (-0.16)

Will Stifel (SF) Gain from 1919 Investment Counsel Buy? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:20PM CST
Stifel (SF) has completed the acquisition of 1919 Investment Counsel. This latest move is in sync with the company's expansion strategy.
SF: 51.81 (-0.04), RJF: 57.73 (-0.02), EVR: 52.54 (-0.16), LM: 54.51 (-0.30)

Ruy Halffter Joins Evercore Casa de Bolsa as Head of the Equity Capital Markets Group
Business Wire - Tue Nov 11, 7:01AM CST
Evercore Casa de Bolsa SA de CV is pleased to announce that Ruy Halffter has joined the Firm as Head of the Mexico Equity Capital Markets Group and will be based in Evercore's office in Mexico City.
EVR: 52.54 (-0.16)

Rising Star Evercore Partners Boosted With ISI Acquisition
FX Analyst - at Seeking Alpha - Tue Nov 11, 6:30AM CST

EVR: 52.54 (-0.16)

Stifel Financial Earnings Lag on High Expenses, Shares Dip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 9:40AM CST
Shares of Stifel Financial Corp. (SF) declined 1.55% to close at $46.90, following third-quarter 2014 results.
SF: 51.81 (-0.04), RJF: 57.73 (-0.02), EVR: 52.54 (-0.16), GCAP: 8.80 (-0.04)

Endeavour Mining files Early Warning Report related to shareholding in Savary Gold
CNW Group - Tue Nov 04, 6:02PM CST
Endeavour Mining Corporation ("Endeavour" or the "Corporation" (TSX:EDV) (ASX:EVR) (OTCQX:EDVMF) has filed an Early Warning Report, as required by National Instrument 62-103, in relation to its shareholding in Savary Gold Corp. ("Savary" (TSXV:SCA).
SCA.VN: 0.025 (unch), EVR: 52.54 (-0.16), EDV.TO: 0.39 (+0.01)

Endeavour Mining Reports Strong Gold Production in Q3 2014 at AISC of $991/oz
CNW Group - Mon Nov 03, 4:10PM CST
Endeavour Mining Corporation ("Endeavour" or the "Corporation" (TSX:EDV) (ASX:EVR) (OTCQX:EDVMF) announces gold production of 117,612 ounces resulting in an all-in sustaining margin of $32.1 million in Q3 2014. The AISC of $991/oz during Q3 2014 is significantly improved from $1,118/oz in Q3 2013. Endeavour continues to benefit from strong performance at Agbaou and is completing a significant optimization and investment phase at Tabakoto.
EVR: 52.54 (-0.16), EDV.TO: 0.39 (+0.01)

Greenhill: What Has Changed?
Ashleigh Rogers - at Seeking Alpha - Mon Nov 03, 1:00PM CST

CG: 26.90 (-0.39), APO: 23.33 (-0.09), GHL: 43.02 (-0.18), LAZ: 50.95 (-0.37), EVR: 52.54 (-0.16), KKR: 23.14 (+0.24), MC: 35.26 (+0.09)

Evercore closes ISI purchase
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:20AM CST

EVR: 52.54 (-0.16)

Evercore Private Funds Group names Ian Bell and Manda Chan as new hires to strengthen Asia Pacific presence
M2 - Mon Nov 03, 7:43AM CST
Evercore (NYSE:EVR) Private Funds Group, an independent investment banking advisory firm, on Saturday named Ian Bell and Manda Chan to its Hong Kong office, expanding the team's current activities in the Asia Pacific region.
EVR: 52.54 (-0.16)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market News: Nasdaq Dips as Applied Materials Shines

Updated Category News Views 191

Stock Market Declines on Nasdaq Today, U.S. stocks faced challenges with the Nasdaq Composite dropping significantly. The market opened lower with declines across major indices, signaling a cautious trading atmosphere. Market Overview As the day progressed, the Dow Jones Industrial Average fell by 1.21% to 46,882.86, while the NASDAQ retreated by 1.51%, settling at...

Continue Reading
Fastly Eyewitness: A Look at Recent Stock Performance

Updated Category News Views 205

Fastly's Impressive Stock Surge Fastly stock has recently shown remarkable movement, trading at near recent highs, indicating strong investor confidence in the company. The notable increase has left many wondering how long this momentum can be sustained. AI Transformation Sparks Interest Shifting Perspectives in Technology The recent ascent of Fastly's stock is largely...

Continue Reading
Exploring the Transformation of Social Media Management Market

Updated Category News Views 139

Understanding the Evolution of the Social Media Management Market The social media management market is experiencing remarkable growth. From a value of $17.5 billion in 2022, projections indicate it may reach $51.8 billion by 2027. This surge represents a compound annual growth rate (CAGR) of 24.2%. Companies worldwide are adapting to the increasing reliance on social...

Continue Reading
WestBond Enterprises Posts Year-End Financial Results and Outlook

Updated Category News Views 166

WestBond Enterprises Financial Overview WestBond Enterprises Corporation (TSX-V: WBE), a notable player in the manufacturing sector, has reported a financial loss of $52,380 for the year ending in March, reflecting a notable decrease from the previous year's loss of $210,683. Despite the loss, the company experienced a 4.9% increase in sales, which totaled $9,673,002,...

Continue Reading
Investors of Ultra Clean Urged to Act Amidst Stock Decline

Updated Category News Views 239

Investigation by Faruqi & Faruqi for Ultra Clean Investors Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who have experienced losses exceeding $50,000 in Ultra Clean Holdings, Inc. (NASDAQ: UCTT). The firm aims to discuss potential legal options available to these investors following troubling financial disclosures from Ultra...

Continue Reading